Answers are grounded in this paper and cite their sources.
Evaluates cognitive improvement and gut microbiota restoration in mice using nobiletin derivative, suggesting therapeutic potential.
BACKGROUND: Nobiletin, a citrus polymethoxyflavone recognized as a functional food component with diverse health benefits, has been reported to exhibit antioxidant, anti-inflammatory and neuroprotective properties. Methylglyoxal (MG), a highly reactive dicarbonyl compound and precursor of advanced glycation end products, contributes to oxidative stress, tau hyperphosphorylation and amyloid-β (Aβ) accumulation, which are key events linking diabetes to Alzheimer's disease. In this study, an acetylated derivative of nobiletin, 5-acetoxy-6,7,8,3',4'-pentamethoxyflavone (5-AN), was evaluated for its neuroprotective and gut microbiota-modulating effects against MG-induced Alzheimer-like cognitive deficits in mice. RESULTS: group showing significant improvement in spatial learning, recognition memory and anxiety-like behavior. Immunohistochemical and Western blot analyses showed that 5-AN reduced hippocampal tau phosphorylation and Aβ accumulation at the same time as restoring phosphoinositide 3-kinase (PI3K)/Akt/glycogen synthase kinase-3β signaling, enhancing brain-derived neurotrophic factor expression and reducing cleaved caspase-3 expression. Gut microbiota analysis showed that MG exposure induced dysbiosis, characterized by reduced Bacteroides_H acidifaciens and increased MG-associated taxa such as Alistipes and Dysosmobacter, whereas 5-AN supplementation significantly reversed these alterations. Functional prediction analysis further indicated that MG-induced dysbiosis was associated with disruptions in neuroimmune-related pathways, including circadian entrainment, Th17 cell differentiation, interleukin-17 signaling and PI3K/Akt signaling, whereas 5-AN supplementation significantly restored these pathways. CONCLUSION: These findings indicate that acetylated nobiletin may serve as a promising food-derived bioactive compound for mitigating cognitive impairment through coordinated modulation of neuronal function and gut microbiota.
No takes yet. Share an insight, caveat, or question.
Tsai et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: